Onyx (ONXX) volatility flat into Kyprolis FDA panel vote

Onyx Pharmaceutical (Nasdaq: ONXX) overall option implied volatility of 50 is near its 26-week average of 53 according to Track Data, suggesting non-directional price movement as shares are halted into a FDA panel vote for Kyprolis.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Ross Stores (ROST) call put ratio 1.1 calls to 1 put into quarter results
• Thermo Fisher Scientific (TMO) call put ratio 4.8 calls to 1 put with a focus on March 700 calls as share price up 4.2%
• Carvana (CVNA) call put ratio 1 call to 2.2 puts with a focus on August 60 puts as share price up 6.3%